Stem cell transplantation: Progress in Asia

Lupus

Volumn 19, Issue 12, 2010, Pages 1468-1473

  Sun, L ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

stem cells; systemic lupus erythematosus; transplantation

Indexed keywords

ANTINUCLEAR ANTIBODY; CD3 ANTIGEN; CD45RA ANTIGEN; CD45RO ANTIGEN; CD8 ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BEHCET DISEASE; CLINICAL ASSESSMENT; FEASIBILITY STUDY; GENETIC POLYMORPHISM; IMMUNOMODULATION; JUVENILE RHEUMATOID ARTHRITIS; MESENCHYMAL STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; PROTEINURIA; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; UMBILICAL CORD;

ASIA; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; STEM CELL TRANSPLANTATION;

EID: 78649742723     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203310370051     Document Type: Review

References (53)

1. Miah T., Haque MA, Mahmood T., Tarafder BK Clinical profile, management and outcome of lupus. Mymensingh Med J 2008 ; 17: S6 - S11.
2. Yang W., Zhao M., Hirankarn N., et al. ITGAM is associated with disease susceptibility and renal nephritis of systemic lupus erythematosus in Hong Kong Chinese and Thai. Hum Mol Genet 2009 ; 18: 2063-2070.
3. Mok CC, Lau CS Lupus in Hong Kong Chinese. Lupus 2003 ; 12: 717-722.
4. Mok CC, Tang SS Incidence and predictors of renal disease in Chinese patients with systemic lupus erythematosus. Am J Med 2004 ; 117: 791-795.
5. Seligman VA, Lum RF, Olson JL, Li H., Criswell LA Demographic differences in the development of lupus nephritis: a retrospective analysis. Am J Med 2002 ; 112: 726-729.
6. Tikly M., Navarra SV Lupus in the developing world - is it any different? Best Pract Res Clin Rheumatol 2008 ; 22: 643-645.
7. Heller T., Ahmed M., Siddiqqi A., Wallrauch C., Bahlas S. Systemic lupus erythematosus in Saudi Arabia: morbidity and mortality in a multiethnic population. Lupus 2007 ; 16: 908-14.
8. Al Arfaj AS, Khalil N. Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia. Lupus 2009 ; 18: 465-473.
9. Chang CC, Shih TY, Chu SJ, et al. Lupus in Chinese male: a retrospective study of 61 patients. Zhonghua Yi Xue Za Zhi (Taipei) 1995 ; 55: 143-150.
10. Mok CC, Mak A., Chu WP, To CH, Wanq SN Long-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups. Medicine (Baltimore) 2005 ; 84: 218-224.
11. Morton JI, Siegel BV Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice. Proc Natl Acad Sci USA 1974 ; 71: 2162-2165.
12. Morton JI, Siegel BV, Moore RD Transplantation of autoimmune potential. II. Glomerulonephritis in lethally irradiated DBA/2 recipients of NZB bone marrow cells. Transplantation 1975 ; 19: 464-469.
13. Taurog JD, Richardson JA, Croft JT, et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994 ; 180: 2359-2364.
14. Knaan-Shanzer S., Houben P., Kinwel-Bohré EP, van Bekkum DW Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation. Bone Marrow Transplant 1991 ; 8: 333-338.
15. Marmont AM Stem cell transplantation for autoimmune disorders. Coincidental autoimmune disease in patients transplanted for conventional indications. Best Pract Res Clin Haematol 2004 ; 17: 223-232.
16. Tyndall A., Saccardi R. Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions. Clin Exp Immunol 2005 ; 141: 1-9.
17. Tyndall A., Gratwohl A. Haemopoietic stem and progenitor cells in the treatment of severe autoimmune diseases. Ann Rheum Dis 1996 ; 55: 149-151.
18. Zimmerman R., Radhakrishan J., Valeri A., Appel G. Advances in the treatment of lupus nephritis. Ann Rev Med 2001 ; 52: 63-68.
19. Mageed RA, Prud'homme GJ Immunopathology and the gene therapy of lupus. Gene Ther 2003 ; 10: 861-874.
20. Furst DE Stem cell transplantation for autoimmune disease: progress and problems. Curr Opin Rheumatol 2002 ; 14: 220-224.
21. Marmont AM, van Lint MT, Gualandi F., Bacigalupo A. Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration. Lupus 1997 ; 6: 545-548.
22. Marmont AM, Burt RK Hematopoietic stem cell transplantation for systemic lupus erythematosus, the antiphospholipid syndrome and bullous skin diseases. Autoimmunity 2008 ; 28: 1.
23. Ouyang J., Sun L., Yang Y., Chen B., Han X., Fan X. A pilot study in treatment of systemic lupus erythematosus by autologous bone marrow transplant. Zhonghua Nei Ke Za Zhi 2001 ; 40: 229-231.
24. Wu SY, Zhao XW, Fu YW, Liu WG, Chen L., Wu Y. Effects of autologous hematopoietic stem cell transplantation on immune function in patient with systemic lupus erythematosus. Zhonggguo Shi Yan Xue Ye Xue Za Zhi 2004 ; 12: 67-69.
25. Li J., Zeng K., Zhou Z., et al. Safety report of autologous peripheral blood stem cell transplantation for systemic lupus erythematosus. J Clin Dermatol 2007 ; 36: 364-366.
26. Li J., Zeng K., Zhou Z., et al. Effect of autologous peripheral blood stem cell transplantation to life quality of systemic lupus erythematosus patients. Chin J Derm Venereol 2006 ; 20: 84-86.
27. Sun L., Sun J., Zeng K., et al. Alteration of autoimmune antibody in patients with systemic lupus erythematosus after autologous peripheral blood purified stem cells transplantation. Chin J Derm Venereol 2009 ; 23: 6-8.
28. Sun L., Sun J., Zeng K., et al. Changes of immune function in patients with systemic lupus erythematosus after autologous peripheral blood purified stem cells transplantation. J Dalian Med Univ 2008 ; 30: 29-32.
29. Fu YW, Zhu P., Zhao XW, et al. The variation of T-cell clonal repertoire in patients with systemic lupus erythematosus (SLE) following autologous peripheral blood hematopoietic stem cell transplantation. Natl Med J China 2003 ; 83: 1648-1651.
30. Pavletic SZ Transplantation for SLE? Blood 2005 ; 106: 2597.
31. Kubota T. Autologous hematopoietic stem cell transplantation in SLE. Clin Rheumatol Related Res 2003 ; 15: 26-29.
32. Hashimoto N., Iwasaki T., Sekiguchi M., et al. Autologous hematopoietic stem cell transplantation for refractory antiphospholipid syndrome causing myocardial necrosis. Bone Marrow Transplant 2004 ; 33: 863-866.
33. Tsukamoto H., Nagafuji K., Horiuchi T., et al. A phase I-II trial of autologous peripheral blood stem cell transplantation in the treatment of refractory autoimmune disease. Ann Rheum Dis 2006 ; 65: 508-514.
34. Na KS, Choi JH, Yoo DH, Kim TY, Ahn MJ, Bae SC Autologous hematopoietic stem cell transplantation in patients with refractory systemic lupus erythematosus. J Korean Rheum Assoc 2003 ; 10: 132-140.
35. Chng HH Management of systemic lupus erythematosus in the coming decade: potentials and challenges. APLAR J Rheumatol 2006 ; 9: 419-424.
36. Tyndall A., Le Blanc K. Stem cells and rheumatology: update on adult stem cell therapy in autoimmune diseases. Arthritis Rheum 2006 ; 55: 521-525.
37. Le Blanc K., Ringden O. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005 ; 11: 321-334.
38. Sun L., Akiyama K., Zhang H., et al. Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells 2009 ; 27: 1421-1432.
39. Zuk PA, Zhu M., Mizuno H., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001 ; 7: 211-28.
40. Weiss ML, Troyer DL Stem cells in the umbilical cord. Stem Cell Rev 2006 ; 2: 155-162.
41. Noort WA, Kruisselbrink AB, Anker PS, et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34+ cells in NOD/SCID mice. Exp Hematol 2002 ; 30: 870-878.
42. Pego-Reigosa JM, Isenberg DA System in systemic lupus erythematosus: pharmacological developments and recommendations for a therapeutic strategy. Expert Opin Investig Drugs 2008 ; 17: 31-41.
43. Tieng AT, Peeva E. B-cell-directed therapies in systemic lupus erythematosus. Semin Arthritis Rheum 2008 ; 38: 218-227.
44. Burt RK, Traynor A., Statkute L., et al. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA 2006 ; 295: 527-535.
45. Le Blanc K., Tammik L., Sundberg B., et al. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003 ; 57: 11-20.
46. Klyushnenkova E., Mosca JD, Zernetkina V., et al. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J Biomed Sci 2005 ; 12: 47-57.
47. Aggarwal S., Pittenger MF Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005 ; 105: 1815-1822.
48. Jiang X., Zhang Y., Liu B., et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 2005 ; 105: 4120-4126. (Pubitemid 40656164)
49. Sotiropoulou PA, Perez SA, Gritzapis AD, et al. Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 2006 ; 24: 74-85.
50. Le Blanc K., Frassoni F., Ball L., et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004 ; 363: 1439-1441.
51. Noort WA, Kruisselbrink AB, in't Anker PS, et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34+ cells in NOD/SCID mice. Exp Hematol 2002 ; 30: 870-878.
52. Sun L., Zhang H., Feng X., et al. Abnormality of bone marrow-derived stem cell in patients with systemic lupus erythematosus. Lupus 2007 ; 16: 121-128. (Pubitemid 46347934)
53. Zhou K., Zhang H., Jin O., et al. Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice. Cell Mol Immunol 2008 ; 5: 417-424.